NEW YORK , Aug. 6, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc....
NEW YORK , Aug. 1, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ:...
Completed Type A meeting with the FDA on bitopertin and aligned that the Phase 3 APOLLO study, if successful, can serve as the basis for CRL response; topline data expected in Q4 2026 Launched Expanded...
NEW YORK , July 27, 2026 /PRNewswire/ --
NEW YORK , July 20, 2026 /PRNewswire/ --
NEW YORK , July 14, 2026 /PRNewswire/ --
NEW YORK , July 10, 2026 /PRNewswire/ --
NEW YORK , June 29, 2026 /PRNewswire/ --
NEW YORK , June 24, 2026 /PRNewswire/ --
NEW YORK , June 19, 2026 /PRNewswire/ --